{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:01:52Z","timestamp":1792839712384,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2892,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Hemochromatosis genotypes have been associated with liver disease, diabetes mellitus, heart disease, arthritis, porphyria cutanea tarda, stroke, neurodegenerative disorders, cancer, and venous disease. We performed meta-analyses including 202 studies with 66,263 cases and 226,515 controls to examine associations between hemochromatosis genotypes C282Y\/C282Y, C282Y\/H63D, C282Y\/wild type, H63D\/H63D, and H63D\/wild type versus wild type\/wild type and 9 overall endpoints and 22 endpoint subgroups. We also explored potential sources of heterogeneity. For liver disease, the odds ratio for C282Y\/C282Y versus wild type\/wild type was 3.9 (99% confidence interval: 1.9\u20138.1) overall, 11 (3.7\u201334) for hepatocellular carcinoma, 4.1 (1.2\u201314) for hepatitis C, and 10 (2.1\u201353) for nonalcoholic steatohepatitis. For porphyria cutanea tarda, the odds ratios were 48 (24\u201395) for C282Y\/C282Y, 8.1 (3.9\u201317) for C282Y\/H63D, 3.6 (1.8\u20137.3) for C282Y\/wild type, 3.0 (1.6\u20135.6) for H63D\/H63D, and 1.7 (1.0\u20133.1) for H63D\/wild type versus wild type\/wild type. Finally, for amyotrophic lateral sclerosis, the odds ratio was 3.9 (1.2\u201313) for H63D\/H63D versus wild type\/wild type. These findings were consistent across individual studies. The hemochromatosis genotypes were not associated with risk for diabetes mellitus, heart disease, arthritis, stroke, cancer, or venous disease in the overall analyses; however, the odds ratio for C282Y\/C282Y versus wild type\/wild type was 3.4 (1.1\u201311) for diabetes mellitus among North Europeans.<\/jats:bold>\n                      <jats:bold>Conclusion:<\/jats:bold>\n                      <jats:bold>In aggregate, clinically ascertained cases who are homozygous for the C282Y mutation are associated with a 4\u201311\u2013fold risk of liver disease, whereas all 5 hemochromatosis genotypes are associated with a 2\u201348\u2013fold risk of porphyria cutanea tarda, and H63D\/H63D is associated with a 4-fold risk of amyotrophic lateral sclerosis. These results, mainly from case-control studies, cannot necessarily be extrapolated to the general population. (HEPATOLOGY 2007.)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.21885","type":"journal-article","created":{"date-parts":[[2007,9,7]],"date-time":"2007-09-07T19:46:18Z","timestamp":1189194378000},"page":"1071-1080","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":125,"title":["Hemochromatosis genotypes and risk of 31 disease endpoints"],"prefix":"10.1097","volume":"46","author":[{"given":"Christina","family":"Ellervik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Birgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u03c6rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20241201","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosisa new look at an old disease.","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-17-20241201","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class Ilike gene is mutated in patients with hereditary haemochromatosis.","volume":"13","author":"Feder","year":"1996","journal-title":"Nat Genet"},{"key":"R4-17-20241201","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.med.57.121304.131310","article-title":"Hemochromatosis: genetics and pathophysiology.","volume":"57","author":"Beutler","year":"2006","journal-title":"Annu Rev Med"},{"key":"R5-17-20241201","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/01.wnl.0000257814.77115.d6","article-title":"Hereditary hemochromatosis genotypes and risk of ischemic stroke.","volume":"68","author":"Ellervik","year":"2007","journal-title":"Neurology"},{"key":"R6-17-20241201","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Metaanalysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R7-17-20241201","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in metaanalyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R9-17-20241201","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0168-8278(02)00305-7","article-title":"Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.","volume":"37","author":"Bonkovsky","year":"2002","journal-title":"J Hepatol"},{"key":"R10-17-20241201","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/j.gastro.2005.09.015","article-title":"Steatosis is a cofactor in liver injury in hemochromatosis.","volume":"129","author":"Powell","year":"2005","journal-title":"Gastroenterology"},{"key":"R11-17-20241201","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11894-003-0005-y","article-title":"Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.","volume":"5","author":"Chitturi","year":"2003","journal-title":"Curr Gastroenterol Rep"},{"key":"R12-17-20241201","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-2005-923317","article-title":"Iron in nonhemochromatotic liver disorders.","volume":"25","author":"Alla","year":"2005","journal-title":"Semin Liver Dis"},{"key":"R13-17-20241201","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","article-title":"Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.","volume":"16","author":"Fargion","year":"1992","journal-title":"HEPATOLOGY"},{"key":"R14-17-20241201","first-page":"135","article-title":"Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in longterm followup.","volume":"19","author":"Kordac","year":"1972","journal-title":"Neoplasma"},{"key":"R15-17-20241201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/mi.6.2.6","article-title":"Iron dysregulation and neurodegeneration: the molecular connection.","volume":"6","author":"Lee","year":"2006","journal-title":"Mol Interv"},{"key":"R16-17-20241201","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1073\/pnas.95.4.1472","article-title":"The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.","volume":"95","author":"Feder","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-17-20241201","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0049-0172(92)90019-A","article-title":"Diseases associated with calcium pyrophosphate deposition disease.","volume":"22","author":"Jones","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"R18-17-20241201","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s003300050274","article-title":"Radiological features of the visceral and skeletal involvement of hemochromatosis.","volume":"7","author":"Jager","year":"1997","journal-title":"Eur Radiol"},{"key":"R19-17-20241201","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G- a (C282Y) HFE hereditary haemochromatosis mutation in the USA.","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"key":"R20-17-20241201","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2003-10-3564","article-title":"Hemochromatosis mutations in the general population: iron overload progression rate.","volume":"103","author":"Andersen","year":"2004","journal-title":"Blood"},{"key":"R21-17-20241201","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/0003-4819-140-5-200403020-00008","article-title":"Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.","volume":"140","author":"Juul","year":"2004","journal-title":"Ann Intern Med"},{"key":"R22-17-20241201","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.0000149380.94984.f0","article-title":"Phenotype of heterozygotes for lowdensity lipoprotein receptor mutations identified in different background populations.","volume":"25","author":"TybjaergHansen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R23-17-20241201","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJMoa041534","article-title":"Hemochromatosis and ironoverload screening in a racially diverse population.","volume":"352","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"R24-17-20241201","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ije\/dyh132","article-title":"Mendelian randomization: prospects, potentials, and limitations.","volume":"33","author":"Smith","year":"2004","journal-title":"Int J Epidemiol"},{"key":"R25-17-20241201","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/hmg\/ddg149","article-title":"Typical type 2 diabetes mellitus and HFE gene mutations: a populationbased casecontrol study.","volume":"12","author":"Halsall","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R26-17-20241201","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.2337\/diabetes.54.12.3567","article-title":"HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women.","volume":"54","author":"Qi","year":"2005","journal-title":"Diabetes"},{"key":"R27-17-20241201","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2362.2006.01711.x","article-title":"HFE mutations and risk of coronary heart disease in middleaged women.","volume":"36","author":"van der A DL, Peeters","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"R28-17-20241201","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2377-6-24","article-title":"Association of HFE common mutations with Parkinsons disease, Alzheimers disease and mild cognitive impairment in a Portuguese cohort.","volume":"6","author":"Guerreiro","year":"2006","journal-title":"BMC Neurol"},{"key":"R29-17-20241201","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2337\/diacare.25.11.2112-a","article-title":"The role of hemochromatosis C282Y and H63D gene mutations in type 2 diabetes: findings from the Rotterdam study and metaanalysis.","volume":"25","author":"Njajou","year":"2002","journal-title":"Diabetes Care"},{"key":"R30-17-20241201","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":", for the MetaAnalysis of Observational Studies in Epidemiology Group. Metaanalysis of observational studies in epidemiology: a proposal for reporting.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21885","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200710000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:06:48Z","timestamp":1733040408000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200710000-00017"}},"subtitle":["Meta-analyses including 66,000 cases and 226,000 controls"],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21885","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1091533.546014","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}